Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Hepion Pharmaceuticals, Inc. | 5,000,000 | reported | 21 Apr 2026 | tx 2+6,250,000 |
| Tharimmune, Inc. | 190,000 | reported | 03 Nov 2025 | tx 1+90,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 21 Apr 2026 | PURCHASE | Hepion Pharmaceuticals, Inc. | 5,000,000 | 0.04 USD | |
| 21 Apr 2026 | PURCHASE | Hepion Pharmaceuticals, Inc. | 1,250,000 | 0.04 USD | |
| 03 Nov 2025 | GRANT_AWARD | Tharimmune, Inc. | 90,000 | 0.00 USD | deriv |